logo
Share SHARE
FONT-SIZE Plus   Neg

StemCells' Phase I Trial In PMD Shows Evidence Of Progressive Myelination

StemCells, Inc. (STEM) revealed preliminary evidence of progressive and durable donor-cell derived myelination in all four patients who underwent transplantation with the company's proprietary HuCNS-SC cells in its clinical trial for Pelizaeus-Merzbacher disease, or PMD, a rare hypo-myelination disorder in children.

In addition, clinical assessment disclosed small but measureable gains in motor and/or cognitive function in three of the four patients; the fourth patient remained clinically stable.

The company noted that the open-label Phase I trial enrolled four patients with the connatal form of PMD, between the ages of 14 months and 5 years, and was designed to assess safety and preliminary efficacy of the intervention. The study used magnetic resonance, or MR, imaging, commonly employed in other neurological diseases, to explore signs of myelination related to the transplanted neural stem cells.

At the one-year interval, MR imaging showed changes compatible with increased myelination in the region of the transplantation.

Further, the company said that a separate four-year observational study will continue to monitor and report the future progress for all four patients.

"The finding of myelin formation in this first exploratory study is indeed very encouraging," said Stephen Huhn, Vice President and Head of the CNS Program at StemCells, Inc. "We believe that the results of this trial provide proof-of-concept and a compelling rationale for the Company to begin planning for a controlled Phase II study in PMD. These results may also have implications for other leukodystrophies, as well as more common myelin disorders including transverse myelitis, multiple sclerosis and periventricular white matter injury seen in Cerebral Palsy..."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Palo Alto Networks, Inc. (PANW) shares are down about 7%, but we think the stock is overreacting. We believe the tidings are not all that bad. Quarterly results and guidance are a mixed bag, in fact. Watch the slide show for more details. Mortgage application volume rose last week, ending two straight weeks of declines, as interest rates held steady. The Market Composite Index, a measure of mortgage loan application volume, increased 2.8 percent on a seasonally adjusted basis for the week ending August 26, from one week earlier, according to the Mortgage Bankers Association or MBA. As part of the launch of "Rogue One: A Star Wars Story," a new toyline was unveiled on Wednesday in a stop motion video created by fans. A series of original animated shorts from Star-war fans starring key toys were used to create the video.
comments powered by Disqus
Follow RTT